Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury

被引：44

作者：

Cuzzocrea, S ^{[1
]}

机构：

[1] Univ Messina, Sch Med, Dept Chem & Expt Med & Pharmacol, Policlin Univ, I-98123 Messina, Italy

来源：

VASCULAR PHARMACOLOGY | 2004年 / 41卷 / 06期

关键词：

PPAR-gamma; ischemia; reperfusion;

D O I：

10.1016/j.vph.2004.10.004

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily of ligand-activated transcription factors that are related to retinoid, steroid and thyroid hormone receptors. The PPAR subfamily comprises of three members, PPAR-alpha., PPAR-beta and PPAR-gamma. PPAR-gamma has recently been implicated as a regulator of cellular proliferation and inflammatory responses. There is good evidence that ligands of PPAR-gamma, including certain thiazolinediones. reduce tissue injury associated with ischemia and reperfusion. The potential utility of PPAR-gamma ligands in ischemia and reperfusion will be discussed in this review. (C) 2004 Elsevier Inc. All rigths reserved.

引用

收藏

页码：187 / 195

页数：9

相关论文

共 71 条

[1] Peroxisome proliferator-activated receptors in the cardiovascular system [J].

Bishop-Bailey, D .

BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (05) :823-833

[2]

BITTERMAN H, 1991, CIRC SHOCK, V33, P183

[3] USE OF A NOVEL PEPTIDE LEUKOTRIENE RECEPTOR ANTAGONIST, LY-163443, IN SPLANCHNIC ARTERY-OCCLUSION SHOCK [J].

BITTERMAN, H ;

LEFER, AM .

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1988, 32 (02) :63-70

[4] Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart - p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion [J].

Bogoyevitch, MA ;

GillespieBrown, J ;

Ketterman, AJ ;

Fuller, SJ ;

BenLevy, R ;

Ashworth, A ;

Marshall, CJ ;

Sugden, PH .

CIRCULATION RESEARCH, 1996, 79 (02) :162-173

[5] SPECIFICITY OF LEUKOCYTE-ENDOTHELIAL INTERACTIONS AND DIAPEDESIS - PHYSIOLOGICAL AND THERAPEUTIC IMPLICATIONS OF AN ACTIVE DECISION-PROCESS [J].

BUTCHER, EC .

RESEARCH IN IMMUNOLOGY, 1993, 144 (09) :695-698

[6] Intestinal (mesenteric) vasculopathy II - Ischemic colitis and chronic mesenteric ischemia [J].

Cappell, MS .

GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1998, 27 (04) :827-+

[7] The cyclopentenone prostaglandin 15-deoxy-Δ12,14-prostaglandin J2 ameliorates ischemic acute renal failure [J].

Chatterjee, PK ;

Patel, NSA ;

Cuzzocrea, S ;

Brown, PAJ ;

Stewart, KN ;

Mota-Filipe, H ;

Britti, D ;

Eberhardt, W ;

Pfeilschifter, J ;

Thiemermann, C .

CARDIOVASCULAR RESEARCH, 2004, 61 (03) :630-643

[8] Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-γ (PPAR-γ), reduce ischaemia/reperfusion injury of the gut [J].

Cuzzocrea, S ;

Pisano, B ;

Dugo, L ;

Ianaro, A ;

Patel, NSA ;

Di Paola, R ;

Genovese, T ;

Chatterjee, PK ;

Di Rosa, M ;

Caputi, AP ;

Thiemermann, C .

BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (02) :366-376

[9] The cyclopentenone prostaglandin 15-deoxy-Δ 12,14-PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat [J].

Cuzzocrea, S ;

Ianaro, A ;

Wayman, NS ;

Mazzon, E ;

Pisano, B ;

Dugo, L ;

Serraino, I ;

Di Paola, R ;

Chatterjee, PK ;

Di Rosa, M ;

Caputi, AP ;

Thiemermann, C .

BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (04) :678-688

[10]

Cuzzocrea S, 2001, PHARMACOL REV, V53, P135

← 1 2 3 4 5 6 7 8 →